Skip to main content
. 2023 Oct 4;16(4):405–411. doi: 10.1136/jnis-2023-020161

Table 1.

Rates of safety from the literature for endovascular treatment of unruptured and ruptured aneurysms

N
Aneurysms (subjects)
Mortality at discharge Overall complication rate Rupture/ perforation rate
(%)
Embolism rate (%)
Ruptured intracranial aneurysms
 Algra et al 2019* 33 73 066 (71 819) 0.3% (0.2–0.4%) 4.96% (4.00, 6.12%) 0.9% (212/18 520)
95% CI (0.6% to 1.3%)
2.82% (437/16 000) 95% CI (2.3% to 3.5%)
 Advanced endovascular methods†33 2248 0.4% (0.2–1.1%) 6.1% (4.3, 8.7%)
 Kawbata et al 201834 1406 (1375) 1.4% (20/1406)
 Coil only 340 1.8% (6/340)
 Stent-assisted coiling 468 0.9% (4/468)
 Balloon-assisted coiling 598 1.7% (10/598)
 From lit review, table 6 in Kawbata34 7785 0% 1.4% (108/7785)
 Zheng et al 201635 1127 1% (11/1127)
 Santillan et al 2013 36 217 0% 1.1% (3/217)
 Shigematsu et al 201337 4767 1.4% (65/4767)
 Oishi et al 201238 500 0% 1.4% (7/500)
 Im et al 200939 435 0% 0.9% (4/435)
 Pierot et al 200840 739 (649) 0.3% 2.4% (18/739) 7.3% (29/398)
 (ATENA study) (700 procs) 1.4% (1 month) 15.4% 2.6% (18/700) 7.1% (per proc)
  Pierot et al 200941
  (ATENA study, coil alone results)
325 0.9% (3/325) 10.8% (35/325) 2.1% (7/325) 6.2% (20/325)
Ruptured intracranial aneurysms
 Zhang et al 201942 1004 All cause 9.5% (5.8%, 13.2%) procedure related 1.8% (0.9, 2.7%) 22.7%‡ 95% CI (15.1% to 30.3%)
  Cognard et al 201143
  (CLARITY GDC study)
405 1.50% 3.7% (15/405) 13.3% (54/405)
 Pierot et al 2011 (CLARITY)44 608 5.1% (31/608) cum. treatment-related morbidity/mortality rate
19.6% (119/608) with. morbidity/mortality rate)
17.4% (106/608) 4.6% (28/608)

*Rates presented are pooled crude risk from meta-analysis modeling.

†Advanced=stent-assisted coiling, balloon-assisted coiling, flow diverting stents or Woven Endobridge devices.

‡Definition not specified.